N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer
US-10111878-B2 · Oct 30, 2018 · US
This page is not indexed by search engines while we improve data quality.
Patent family 51261261
This patent family groups 4 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 51261261 |
| Family type | — |
| Earliest priority | Jul 11, 2013 |
| First filing country | US |
| Member publications | 4 |
| Countries | US |
| Representative publication | US10111878B2 — N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer |
Representative publication
Best representative member for this family based on priority and filing country.
US10111878B2 — N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer (published Oct 30, 2018)
Member publications
Related publications in this family.
N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as idh2 mutants inhibitors for the treatment of cancer
US-2017348318-A1 · Dec 7, 2017 · US
N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer
US-9724350-B2 · Aug 8, 2017 · US
N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as idh2 mutants inhibitors for the treatment of cancer
US-2016158241-A1 · Jun 9, 2016 · US